Definitive Healthcare Corp. reported a revenue of $55.9 million for the first quarter of 2026, a decrease of 6% compared to $59.2 million in the same period of the previous year. The decline was primarily attributed to a $3.7 million drop in subscription revenue, partially offset by a $0.5 million increase in professional services revenue. The company experienced a net loss of $192.4 million, which included a significant goodwill impairment charge of $197.2 million, compared to a net loss of $155.1 million in the prior year, which also included a goodwill impairment charge of $176.5 million.
In terms of operational metrics, Definitive Healthcare's customer count decreased to approximately 2,260 as of March 31, 2026, down from 2,475 a year earlier. The number of Enterprise Customers, defined as those generating over $100,000 in annual recurring revenue, also fell from 512 to 495. The company noted that macroeconomic conditions have led to increased customer churn, particularly among smaller clients, which has negatively impacted revenue growth.
Strategically, the company has initiated a restructuring plan aimed at reducing operating costs and improving margins, which included a workforce reduction of approximately 40 employees. This restructuring resulted in charges of about $1.1 million during the quarter. Additionally, the company has been focusing on enhancing its product offerings and expanding its platform capabilities, although it has faced challenges in sales execution due to changes in its go-to-market strategy.
Looking ahead, Definitive Healthcare anticipates continued pressure on revenue growth due to macroeconomic challenges and a competitive landscape. The company expects to see a negative revenue growth rate for 2026 compared to 2025, driven by elongating deal cycles and lower renewal rates. Despite these challenges, there are signs of improvement in customer demand and retention dynamics, which the company plans to monitor closely as it navigates the current market conditions.
About Definitive Healthcare Corp.
Definitive Healthcare provides SaaS-based healthcare commercial intelligence, aggregating extensive data on providers, facilities, and market activities. Its platform uses AI and analytics to help clients optimize market entry, sales, and product development in the U.S. healthcare ecosystem. Serving life sciences, providers, and tech companies, it offers differentiated, high-quality insights to support strategic decision-making and competitive advantage.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.